Overview

Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients

Status:
Completed

Trial end date:
2012-09-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the effect of the basal-bolus detemir-aspart insulin regimen coupled with continuous glucose monitoring (CGM) on glycemic control in hemodialyzed patients with diabetes

Phase:

Phase 4

Details

Lead Sponsor:

Centre Europeen d'Etude du Diabete

Collaborators:

Abbott
Novo Nordisk A/S

Treatments:

Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting